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Objective:  The  transient  increase  of the  cytoplasmic  free  calcium  level  plays  a  key  role  in  the  process  of
lymphocyte  activation.  Kv1.3  and  IKCa1  potassium  channels  are  important  regulators  of the  maintenance
of calcium  inﬂux  and  present  a possible  target  for selective  immunomodulation.
Design:  Case–control  study.
Subjects  and  methods:  We  took  peripheral  blood  samples  from  8  healthy  individuals  and  15 primary
Sjögren’s  syndrome  (pSS)  patients.  We  evaluated  calcium  inﬂux  kinetics  following  activation  in  peripheral
T lymphocytes.  We  also  assessed  the  sensitivity  of T lymphocytes  to speciﬁc  inhibition  of  the  Kv1.3  and
IKCa1  potassium  channels,  and the Kv1.3  channel  expression.
Results:  The  basal  cytoplasmatic  calcium  levels  were  lower  in both  Th1  and  Th2 lymphocytes  in  pSS  com-
pared  to controls.  The  peak  of calcium  inﬂux  in  lymphocytes  isolated  from  pSS patients  is reached  later,
indicating  that  they  respond  more  slowly  to stimulation  compared  to controls.  In healthy  individuals,
the  inhibition  of  the  IKCa1  channel  decreased  calcium  inﬂux  in Th2  and  CD4  cells  to  a  lower  extent  than
in  Th1  and  CD8  cells.  On the  contrary,  the  inhibition  of Kv1.3  channels  resulted  in  a larger  decrease  of
calcium  entry  in Th2  and  CD4  than  in  Th1  and  CD8  cells.  In  the  pSS  group,  neither  of the  inhibitors  induced
alteration  in  calcium  inﬂux.  Expression  of  Kv1.3  channels  on CD4,  Th2  and  CD8  lymphocytes  in  pSS  was
signiﬁcantly  higher  compared  to controls.
Conclusion:  The  altered  expression  and  speciﬁc  inhibition  of  potassium  channels  seem  to  be  related  to
altered  calcium  inﬂux  kinetics  in  pSS  which  distinguish  pSS  either  from  healthy  controls  or other  systemic
autoimmune  diseases.
© 2016  Elsevier  GmbH.  All  rights  reserved.. Introduction
Pathways of calcium homeostasis participate in a number of
ellular processes that determine short and long-term function ofPlease cite this article in press as: Legány, N., et al., Calcium inﬂux
lymphocytes in primary Sjögren’s syndrome. Immunobiology (2016), 
 lymphocytes. The increase of the cytoplasmic calcium concen-
ration from intra- and extracellular sources (i.e., the endoplasmic
eticulum and store-operated calcium entry through the plasma
Abbreviations: AUC, area under the curve; [Ca2+]cyt, cytoplasmic free calcium
evel; CRAC, calcium release activated calcium; Max, maximum value; MGTX, mar-
atoxin; PBMC, peripheral blood mononuclear cell; PHA, phytohemagglutinin; pSS,
rimary Sjögren’s syndrome; RA, rheumatoid arthritis; TCM, central memory T cell;
EM, effector memory T cell; Th, T helper; tmax, time to reach maximum value; TRAM,
riarylmethane.
∗ Corresponding author.
E-mail address: balog.attila@med.u-szeged.hu (A. Balog).
ttp://dx.doi.org/10.1016/j.imbio.2016.06.004
171-2985/© 2016 Elsevier GmbH. All rights reserved.membrane) is the cornerstone of T lymphocyte activation and func-
tionality. Over the recent year, an increasing number of calcium
channels and transporters have been described that play a key role
in balancing cytoplasmic calcium levels in T cells. (Toldi, 2013;
Feske, 2013).
In the course of lymphocyte activation, potassium channels
maintain the driving force for sustained calcium inﬂux from the
extracellular milieu as they grant the efﬂux of potassium from the
cytoplasm, thus conserving an electrochemical potential gradient
between the intra- and extracellular spaces. There are two major
types of potassium channels in T cells: the voltage gated Kv1.3
and the calcium-activated IKCa1 channels (Orbán et al., 2013). The
relation between the calcium currents through calcium release kinetics, and the features of potassium channels of peripheral
http://dx.doi.org/10.1016/j.imbio.2016.06.004
activated calcium (CRAC) channels and the efﬂux of potassium
makes the proliferation and activation of lymphocytes sensitive
to pharmacological modulation of Kv1.3 and IKCa1 channels, and
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Table 1
Clinical characteristics of study participants.
Characteristics Healthy individuals n = 8 pSS patients n = 15
Age (years) 53 (42–61) 52 (36–77)
Gender (male/female) 2/6 1/14
pSS duration (years) – 5 (2–14)
Anti-SSA/B positivity – 15
LSG biopsy positivity – 12
ESSDAI 2 (0–4)
ESR (mm/h) 8 (5–12) 27* (7–55)
Data are expressed as median (interquartile range) for continous variables and as
number for categorical variables. pSS, primary Sjögren’s Syndrome; LSG biopsy, focal
lymphocytic sialadenitis (FLS) with focus score ≥ 1 in labial salivary gland (LSG)
biopsy; Anti-SSA/B anti-SSA/B autoantibodies; ESSDAI, EULAR Sjögren’s syndrome
disease activity; ESR, erythrocyte sedimentation rate.ARTICLEMBIO-51494; No. of Pages 7
 N. Legány et al. / Immun
rovides an opportunity for targeted intervention. Speciﬁc inhi-
ition of these channels results in a diminished calcium inﬂux in
ymphocytes and a lower level of lymphocyte activation. Previous
ata suggest that selective modulation of lymphocyte activation
hrough speciﬁc inhibition of potassium channels may  be a possi-
le therapeutic approach for the treatment of autoimmune disease
Beeton et al., 2006; Rangaraju et al., 2009).
Furthermore, a different characteristic potassium channel phe-
otype of effector memory T cells was described in multiple
clerosis (MS): terminally differentiated effector memory T (TEM)
ells exhibit Kv1.3high IKCa1low channel phenotype, contrast-
ng naïve, and central memory T cells, which exhibit a Kv1.3low
KCa1high channel phenotype (Wulff et al., 2003).
Although results from animal models are promising, limited
ata is available on the effects of potassium channel inhibition on T
ell function in humans. Furthermore, besides naïve and memory T
ells, alterations in the activation pattern of effector (CD4+ helper
nd CD8+ cytotoxic) T lymphocytes have not been described upon
v1.3 and IKCa1 inhibition. Although these cells might have a less-
peciﬁc role in the maintenance of autoreactivity compared to TEM
ells, their inhibition have important consequences on the overall
mmune response.
Therefore, over the recent years, we have investigated calcium
nﬂux characteristics in effector T cell subsets in a number of
utoimmune diseases (Toldi et al., 2010, 2011, 2013, 2015).
In this study we focused on primary Sjögren’s syndrome (pSS).
SS is a chronic autoimmune inﬂammatory disorder that primar-
ly affects exocrine glands leading to their functional impairment.
lthough pSS etiology is not fully elucidated, it is well established
hat the interplay between genetic, environmental and hormonal
actors represents the trigger of aberrant autoimmune response
ith B and T lymphocyte hyperactivity, autoantibody produc-
ion and progressive destruction of target organs. The pathological
allmark of pSS is a chronic mononuclear cell inﬁltrate affecting
xocrine glands mainly driven by T helper (Th) 1-type cytokines.
he innate and adaptive immune responses both play an impor-
ant role in this pathological process. Growing evidence suggests
hat CD4+ Th cells are predominant, and the Th1/Th2 balance shifts
n favor of Th1 in gland, but Th2 cytokine repertoire prevails in sera
Tzioufas et al., 2012).
Therefore, in this study we aimed to characterize the effects of
ymphocyte potassium channel inhibition on short-term periph-
ral blood T lymphocyte activation in major lymphocyte subsets of
atients diagnosed with pSS. We employed a kinetic ﬂow cytom-
try method to describe calcium inﬂux characteristics of the CD4,
h1, Th2 and CD8 subsets and its sensitivity to the inhibition of
v1.3 and IKCa1 lymphocyte potassium channels.
. Materials and methods
.1. Patients
We  enrolled 8 healthy individuals and 15 patients with pri-
ary Sjögren’s Syndrome (pSS). pSS patients fulﬁlling American
uropean Consensus group (AECG) 2002 or American College of
heumatology (ACR) 2012 classiﬁcation criteria were included
Vitali et al., 2002; Shiboski et al., 2012). Clinical parameters of
tudy participants are summarized in Table 1. The following clin-
cal symptoms occurred in pSS patients history: sicca parameters
100%), cytopenia and anemia of autoimmune origin (87%), arthri-
is (67%), vasculitis (53%), anti-SSA/B antibody positivity (100%),Please cite this article in press as: Legány, N., et al., Calcium inﬂux
lymphocytes in primary Sjögren’s syndrome. Immunobiology (2016),
ow C3/C4 complement level (47%), renal involvement (13%), fever
nd night sweats (20%), lymphadenopathy (20%), lymphoma (0%),
eight loss (33%), myositis (7%), peripheral neuropathy (20%). The
ULAR Sjögren’s syndrome disease activity (ESSDAI) scores were* p < 0.05 vs. healthy individuals.
calculated at the time of sampling (Seror et al., 2015). The ESSDAI
score was 2 corresponding to low disease activity. All pSS patients
received a variety of disease modifying antirheumatic drugs
(DMARDs), containing at least one of the following components:
chloroquine, methylprednisolone, methotrexate and azathioprine.
Healthy controls had a negative history of rheumatic symptoms
and negative status upon detailed physical and laboratory examina-
tion. No co-morbidities were detected in patients and controls that
could have inﬂuenced our investigation, nor did they take any med-
ication that could have interfered with the measurements. Written
informed consent was  obtained from all subjects, and our study was
reviewed and approved by an independent ethical committee of the
university. Laboratory studies and interpretations were performed
on coded samples lacking personal and diagnostic identiﬁers. The
study was adhered to the tenets of the most recent revision of the
Declaration of Helsinki.
2.2. Fluorescent staining
Our measurements were carried out as described earlier (Toldi
et al., 2011). Brieﬂy, peripheral blood mononuclear cells (PBMCs)
were isolated by a standard density gradient centrifugation from
9 mL  of freshly drawn peripheral venous blood and afterwards
kept in a modiﬁed RPMI medium (calcium concentration: 2 mM)
throughout the following steps of the procedure. PBMCs were then
incubated with the following conjugated anti-human monoclonal
antibodies in order to differentiate T lymphocyte subsets: anti-CD4
PE-Cy7, anti-CD8 APC-Cy7, anti-CXCR3 APC (for the determination
of Th1 cells) and anti-CCR4 PE (for the deter-mination of Th2 cells)
(all from PharMingen, San Diego, CA, USA), as well as anti-Kv1.3
channel FITC (Sigma–Aldrich, St. Louis, MO,  USA), according to the
manufacturers’ instructions. For monitoring [Ca2+]cyt, PBMCs were
loaded with calcium sensitive Fluo-3 and Fura-Red dyes according
to the manufacturer’s recommendations (Invitrogen, Carlsbad, CA,
USA).
2.3. Flow cytometry
PBMCs were equally distributed into three vials. The ﬁrst vial
was used as control. The second vial was treated with margatoxin
(MGTX, 60 nM), a selective blocker of the Kv1.3 channel. The third
vial was  treated with a triarylmethane compound (TRAM, 60 nM),
a speciﬁc inhibitor of the IKCa1 channel. PBMCs were activated by
the addition of 20 g phytohemagglutinin (PHA) and the measure- kinetics, and the features of potassium channels of peripheral
 http://dx.doi.org/10.1016/j.imbio.2016.06.004
ments were initiated directly afterwards on a BD FACSAria ﬂow
cytometer. Cell ﬂuorescence data were measured and recorded for
15 min  in a kinetic manner.
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Table  2
Prevalence of lymphocyte subsets in the overall lymphocyte population gated
according to Forward Scatter Characteristics (FSC) and Side Scatter Characteristics
(SSC) in 8 healthy individuals and 15 pSS patients.
Subset Healthy pSS
CD4+/ly 37.7(32.4–44.6) 43.4(30.6–52.1)
CXCR3+/CD4 29.8(17.6–34.7) 20.4(15.7–22.9)
CCR4+/CD4 18.9(12.5–26.3) 13.1 (8.8–23.6)
CD4+ CXCR3+/CD4+ CCR4+ ratio 1.89(1.27–2.88) 1.25(0.84–2.56)
CD8+/ly 15.4(9.02–25.6) 17.7(14.6–23.3)
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tata are expressed as median [interquartile range]. CD4+ CXCR3+—Th1 subset, CD4+
CR4+—Th2 subset, ly—overall lymphocyte population, pSS—primary Sjögren’s syn-
rome.
.4. Data evaluation
Recordings were evaluated with our speciﬁc software (FacsKin),
ased on the calculation of a double-logistic function for each
ecording (Toldi et al., 2011). This function is used to characterize
easurements that have an increasing and a decreasing inten-
ity as time passes. The software also calculated parameter values
escribing each function, such as the Area Under the Curve (AUC),
aximum (Max), time to reach maximum (tmax), and Slope values.
UC values correspond to the sum of [Ca2+]cyt increase, which fur-
her corresponds to the level of lymphocyte activation. Max  values
epresent the peak value of the calcium inﬂux curve upon lympho-
yte activation. Tmax values describe how soon the peak value of
he calcium inﬂux curve is reached. The Slope value reﬂects how
apidly the peak of calcium inﬂux is reached. A detailed description
f the evaluation process can be found at www.facskin.com.
Statistics Data are expressed as median and interquartile range.
omparisons between two sample groups were made with the
ann–Whitney test. For comparisons between paired values in the
ame group Wilcoxon tests were applied. P values less than 0.05
ere considered signiﬁcant. Statistics were calculated using the R
oftware.
. Results
.1. Clinical data
As seen in Table 1, the age and gender distribution of participants
ere similar in both study groups. Inﬂammatory parameters (ery-
hrocyte sedimentation rate and C reactive protein values) were
igher in pSS patients than in healthy controls.
The number of patients in different subgroups according to ther-
peutic intervention was limited, and no signiﬁcant differences
n the investigated parameters were observed between the sub-
roups.
.2. The frequency of the investigated lymphocyte subsets
We  determined the frequency of CD4, Th1, Th2 and CD8, cells
n samples of both study groups. CD4+ CXCR3+ cells were regarded
s Th1 lymphocytes, while CD4+ CCR4+ cells were regarded as the
h2 subset. It was no detected signiﬁcant difference regarding indi-
idual cell subsets among the study groups (Table 2).
.3. Basal cytoplasmatic calcium levels in the investigated
ymphocyte subsets
We  evaluated the ratio of the basal median ﬂuorescence of cal-Please cite this article in press as: Legány, N., et al., Calcium inﬂux
lymphocytes in primary Sjögren’s syndrome. Immunobiology (2016), 
ium binding dyes in lymphocytes of both study groups. Before the
ymphocyte activation, the basal median ﬂuorescence of calcium
inding dyes was lower in both Th1 and Th2 lymphocyte subsets in
he pSS group (CD4+ CXCR3: 24,494 [12,365–50,658], CD4+ CCR4+:Fig. 1. The basal mean ﬂuorescence intensity of calcium binding dyes in the inves-
tigated lymphocyte subsets in healthy individuals and primary Sjögren’s syndrome
patients. * p < 0.05 vs. control # p < 0.05 vs CD8.
22768 [9110–44,026]) than in the healthy group CD4+ CXCR3:
26,151 [22,324–28,949], CD4 + CCR4: 28,187 [26,149–31,163] arbi-
trary units, p < 0.05 (median [interquartile range]) respectively
(Fig. 1).
There was no difference between the study groups in CD8+
pSS: 26,483 [12,251–50,510], healthy: 29,797 [22,307–33,994]
lymphocyte ﬂuorescence. The basal cytoplasmatic calcium level
was higher in the CD8+ subsets than in the CD4+ and Th1 sub-
sets in the control group (CD8+: 29,797 [22,307–33,994], CD4+:
26,843 [23,925–28,502], CD4 + CXCR3: 26,151 [22,324–28,949]
p < 0.05 (median [interquartile range])), but in the pSS samples,
there was  no difference among the lymphocyte subsets (CD4+:
25,167 [12,126–44,988], CD4+ CXCR3: 24,494 [12,365–50,658],
CD4+ CCR4: 22,768 [9110–44,026], CD8+: 26,483 [12,251–50,510]
(median [interquartile range])) (Fig. 1).
3.4. Calcium inﬂux kinetics
After lymphocyte activation with PHA, intracellular calcium
inﬂux kinetics were measured with calculated parameter values
(AUC, Max, tmax, and slope) in healthy subjects and in pSS patients
(Table 3). In the CD4+ population, AUC and Max values were lower
in the pSS group compared to the healthy group. For Th1 lympho-
cytes, the AUC value was  lower in pSS samples than in the control
group. In the case of Th2 and CD8+ lymphocytes, the calculated
parameter values showed no signiﬁcant difference among the study
groups (Table 3, Fig. 2).
3.5. The effects of potassium channel inhibitors on lymphocyte
calcium inﬂux
We measured the effect of potassium channel inhibitors (MGTX,
TRAM) in both pSS and healthy groups. Our results revealed that the
sensitivity of Th1 and Th2 cells to IKCa1 channel inhibition was  dif-
ferent in lymphocytes isolated from healthy individuals (Table 3).
Treatment with TRAM, the speciﬁc inhibitor of the IKCa1 channel
decreased calcium inﬂux in Th2 cells to a lower extent than in Th1
cells. On the contrary to IKCa1, the inhibition of Kv1.3 channels
resulted in a larger decrease of calcium entry in Th2 than in Th1
cells. In healthy individuals, CD4 cells were more sensitive to the kinetics, and the features of potassium channels of peripheral
http://dx.doi.org/10.1016/j.imbio.2016.06.004
inhibition of Kv1.3 channels than the CD8 subset, responding with
a higher level of decrease of the AUC value upon the application
of MGTX. However, upon treatment with TRAM, CD8 cells showed
a larger decrease in AUC and Max  values than CD4 cells (Table 3).
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Table 3
The effects of the speciﬁc inhibitor of the Kv1.3 channel, margatoxin (MGTX) and the speciﬁc inhibitor of the IKCa1 channel, triarylmethane (TRAM) application on parameter
values (AUC − Area under the curve in units (U), Max  − maximum value in relative parameter value (rpv), tmax − time to reach maximum value in seconds (s)) of calcium
inﬂux  kinetics in peripheral lymphocytes obtained from 8 healthy individuals and 15 pSS patients.
No inhibitor MGTX (60 nM)  TRAM (60 nM)
Subset Healthy pSS Healthy pSS Healthy pSS
CD4+ AUC (U) 2591 (2349–2939) 2033a (1936–2255) 2328b (2226–2353) 2110 (2043–2168) 2483 (2325–2723) 2084 (1923–2319)
Max  (rpv) 1.46 (1.249−1.608) 1.115a (1.036−1.215) 1.207b (1.141−1.22) 1.085 (1.049−1.121) 1.303 (1.198−1.483) 1.143 (1.033−1.227)
tmax (s) 631.9 (471.7–930.1) 504.3 (355.4–576.3) 913.5 (666.2–1351) 598.4 (427.2–799.3) 755.2 (564.4–972.7) 464.2 (131.6–578.4)
CD4+  CXCR3+ AUC (U) 2411 (2325–2508) 2162a (1896–2358) 2358 (2336–2511) 2067 (1972–2142) 2204b (2151–2235) 2104 (1958–2262)
Max  (rpv) 1.284 (1.203−1.335) 1.122 (1.022−1.298) 1.134b (1.096−1.155) 1.081 (1.053−1.166) 1.231 (1.199−1.34) 1.066 (1.024−1.198)
tmax (s) 674.8 (472.7–1003) 552.8 (189.1–646.6) 901.6 (756–990) 604.1 (432.5–782.3) 872.9 (645.3–1096) 652.4 (511.2–1100)
CD4+  CCR4+ AUC (U) 2289 (2158–2521) 1984 (1718–2396) 2136b (2086–2189) 2204 (1737–2331) 2306 (2136–2396) 2297 (2027–2537)
Max  (rpv) 1.239 (1.099−1.361) 1.097 (1.006−1.222) 1.088 (1.057−1.12) 1.278 (1.144−1.359) 1.192 (1.09−1.249) 1.164 (1.104−1.407)
tmax (s) 791.1 (626.6–1046) 615.3 (345.3–906.1) 1065 (889.2–1215) 677.5 (535.6–711.1) 1034 (885.5–1149) 900.3 (382.8–1117)
CD8+  AUC (U) 2285 (2220–2444) 2164 (2105–2423) 2258 (2224–2318) 2199 (2121–2667) 2404 (2265–2471) 2322 (1964–2566)
Max  (rpv) 1.181 (1.141−1.317) 1.213 (1.09−1.365) 1.156 (1.141−1.198) 1.174 (1.137−1.355) 1.213 (1.067−1.521) 1.257 (1.159−1.284)
tmax (s) 648.1 (519.4–1014) 531.7 (436.3–682.5) 988.1 (671.6–1076) 659.5 (455.8–856.5) 606.6 (541.9–927.9) 590.2 (388.9–1001)
CD4+, CD4+ CXCR3+, CD4+ CCR4+ and CD8+ cells were gated from the overall lymphocyte population. Data are expressed as median [interquartile range]. CD4+ CXCR3+ −
Th1  subset, CD4+ CCR4+ − Th2 subset, pSS − primary Sjögren’s syndrome. c MGTX and TRAM treated samples were compared with samples with no inhibitor application
within lymphocytes isolated from pSS patients, p < 0.05.
a Lymphocytes isolated from pSS patients were compared with lymphocytes isolated from healthy individuals within samples with no inhibitor application, p < 0.05.
b MGTX and TRAM treated samples were compared with samples with no inhibitor application within lymphocytes isolated from healthy individuals, p < 0.05.
Fig. 2. Calcium inﬂux kinetics in peripheral Th1 lymphocytes of healthy individuals and pSS patients upon activation of samples with phytohemagglutinin (data of a
representative sample from each group). For Th1 lymphocytes, the AUC value was  lower in pSS samples than in the control group. The basal [Ca2+]cyt was  lower in pSS
c cium inﬂux reaches its peak later upon activation, and a lower Max compared to healthy
c
A maximum value, tmax—time to reach maximum
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lompared to healthy individuals. This is represented by higher tmax values, i.e. cal
ontrols.
bbreviations: pSS—primary Sjögren syndrome, AUC—area under the curve, Max—
n the pSS group, neither of the inhibitors induced alteration in
alcium inﬂux of lymphocytes (Table 3, Fig. 4).
.6. Kv1.3 channel expression in pSS in the investigated
ymphocyte subsets
We  observed a signiﬁcantly higher Kv1.3 channel expression in
D4+, Th2, and CD8+ lymphocyte subsets in pSS samples than in
ontrol lymphocytes. The median ﬂuorescence of the study groups
as similar in the case of the Th1 lymphocyte subsets. There was  no
ifference among the several control lymphocyte subsets (Fig. 3).
. Discussion
.1. Calcium inﬂux kinetics during lymphocyte activationPlease cite this article in press as: Legány, N., et al., Calcium inﬂux kinetics, and the features of potassium channels of peripheral
lymphocytes in primary Sjögren’s syndrome. Immunobiology (2016), http://dx.doi.org/10.1016/j.imbio.2016.06.004
We  applied a novel ﬂow cytometry-based approach for the
etection of calcium inﬂux. Until the recent past, single-cell tech-
iques were used for the investigation of calcium inﬂux during
ymphocyte activation. There has been no high-throughput method
Fig. 3. Mean ﬂuorescence intensity of the anti-Kv1.3 channel antibody in the inves-
tigated lymphocyte subsets in healthy individuals and primary Sjögren’s syndrome
patients. * p < 0.05 vs. control # p < 0.05 vs Th1.
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sig. 4. The effects of the speciﬁc inhibitor of the Kv1.3 channel, margatoxin (MGTX
arameter values AUC—area under the curve in units (U) in peripheral lymphocyte
p  < 0.05 vs. control.
vailable to study the kinetics of lymphocyte activation in more
ubsets at the same time. Single-cell techniques are restricted by
ot being capable of characterizing this process in complex cel-
ular systems, thus ignoring the interaction between the different
ymphocyte subsets that may  modulate the course of their activa-
ion. Therefore, over the recent years we have developed a novel
lgorithm that allows simultaneous monitoring of calcium inﬂux
n several lymphocyte subsets. Our software (FacsKin) ﬁts func-
ions to median values of the data of interest and calculates relevant
arameters describing each function. By selecting the best ﬁtting
unction, this approach provides an opportunity for the mathemat-
cal analysis and statistical comparison of kinetic ﬂow cytometry
easurements of distinct samples (Toldi et al., 2011).
.2. Basal cytoplasmatic calcium levels and calcium inﬂux
inetics in the investigated lymphocyte subsets
Several animal models have already demonstrated that the
educed TCR signal causes increased susceptibility to autoimmune
iseases. SKG mice have a genetic defect in ZAP-70, a key sig-
al transduction molecule in T-cells leading to T-cells mediated
utoimmune arthritis, and other autoimmune disorders. This defect
ttenuates the TCR signal therefore negative and positive selec-
ion of T cells is impaired in the thymus promoting self-reactive
yporesponsiveness of T-cell selection. On the other hand alloanti-
ens induce sufﬁcient response in ZAP-70 deﬁcient autoreactive
-cells. Our previous observation in type one diabetes and rheuma-
oid arthritis are in line with animal models (e.g. collagen induced
rthritis) where autoimmunity can be triggered by exuberant T cell
esponses. However, our results in primary Sjögren syndrome are
ather comparable to SKG animal models with sub-optimal T cell
ctivation (Sakaguchi et al., 2012).
In contrast with our previous studies in autoimmune disorders,
ultiple sclerosis, rheumatoid arthritis, and type one diabetes, we
ound that lymphocytes isolated from pSS patients respond slowler
o stimulation than those of healthy individuals (Toldi et al., 2013).
urthermore, the ﬁndings of our study indicate that basal [Ca2+]cyt
as lower in pSS compared to healthy individuals. This is repre-Please cite this article in press as: Legány, N., et al., Calcium inﬂux
lymphocytes in primary Sjögren’s syndrome. Immunobiology (2016), 
ented by higher tmax values, i.e. calcium inﬂux reaches its peak
ater upon activation, and a lower AUC compared to healthy con-
rols (Table 3, Fig. 2). This ﬁnding is especially relevant in the Th1
ubset, also indicating that Th1 responses peripherally might be the speciﬁc inhibitor of the IKCa1 channel, triarylmethane (TRAM) application on
ined from 8 healthy individuals and 15 and primary Sjögren’s syndrome patients.
decreased in pSS to control the ongoing inﬂammation (Cornec et al.,
2014).
The pathological hallmark of pSS is a chronic mononuclear cell
inﬁltrate affecting exocrine glands mainly driven by T helper (Th)
1-type cytokines (Beeton et al., 2006). Recently, however, growing
evidence has been suggesting that the pro-inﬂammatory cytokine
interleukin (IL)-17 plays a pivotal role in the pathogenesis of pSS
(Gong et al., 2014). Additionally, presence of different T cell subsets
was evidenced in pSS, in peripheral blood and in salivary glands.
At least six Th subsets exist: Th0, Th1, Th2, Th17, regulatory T
(Treg), and follicular helper T (Tfh) cells, which are suggested to be
involved in the pathogenesis of pSS (Toldi et al., 2011). The salivary
glands are predominantly inﬁltrated by CD4 + T helper (Th) cells
at an early stage of pSS, and in advanced stage, B cells predomi-
nate and these inﬁltration extends to occupy the acinar epithelium
(SjögrenIgG4) (Nocturne and Mariette, 2013). Additionally, besides
conventional CD4+ Th17 cells, another IL-17-producing T-cell sub-
population, lacking both CD4 and CD8 surface molecules (double
negative, DN) has a key role in the pathogenesis of pSS (Alunno
et al., 2014).
Furthermore, an epigenome-wide DNA methylation study iden-
tiﬁed several genes which were hypo or hypermethylated in
peripheral naïve CD4 + T cells from pSS patients compared to
healthy controls (Altorok et al., 2014). Hypomethylated genes were
mainly involved in lymphocyte activation and immune response,
whereas hypermethylated genes were involved in antigen process-
ing and presentation.
In this study, all pSS patients were enrolled after longer onset of
disease (years after the presentation of the diagnosis) without any
severe systemic manifestations (low ESSDAI) at time of blood sam-
pling. Theoretically, all of these observations in pSS including the
role of different Th subsets, the presence of different T cell subsets
in peripheral blood and in salivary glands might partially explain
the decreased reactivity of peripheral Th1 and Th2 lymphocytes in
pSS and the absence of signiﬁcant difference regarding individual
cell subsets among the study groups.
Muscarinic acetylcholine receptor (M3R) is expressed in
exocrine glands and plays crucial roles in exocrine secretion.
Acetylcholine binds to and activates M3R  on salivary gland cells, kinetics, and the features of potassium channels of peripheral
http://dx.doi.org/10.1016/j.imbio.2016.06.004
causing a rise in intracellular Ca2+ concentration via inositol 1, 4,
5-triphosphate (IP3) and IP3 receptors. Similarly to T cell activa-
tion, the increase of the cytoplasmic calcium concentration is the
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ornerstone of salivary gland cells and functionality. Several anti-
3R antibodies (Abs) were described in pSS. These anti-M3R Abs
ause salivary dysfunction in pSS via reduction in Ca2+ inﬂux and
own-regulation of M3R  molecules on epithelial cells of salivary
lands. Next to the destruction of affected tissues (mainly salivary
nd lacrimal glands) another feature of pSS is B cell hyperactiv-
ty, as attested by abundant production of autoantibodies (Sumida
t al., 2014). Autoimmune responses are mainly polyclonal, target-
ng multiple epitopes within the same or interacting autoantigens.
espite extensive studies, the mechanisms operating for the expo-
ure of certain intracellular autoantigens to the immune system
emain rather elusive. It is tempting to speculate potential Abs
ause Th1 and Th2 peripheral lymphocytes dysfunction via altered
alcium inﬂux kinetics in pSS.
Based on our results, the time when the peak of calcium
nﬂux was reached decreased in autoimmune patients compared
o healthy individuals, indicating that these cells are in a state
f sustained reactivity due to the ongoing autoimmune reaction.
ontrary, not only the time when the peak of calcium inﬂux was
eached increased signiﬁcantly, but the peak of calcium inﬂux
ecreased signiﬁcantly too, indicating that these cells are in an
nsensitive state which suggests the distinct pathomechanism of
SS (Table 3, Fig. 2).
.3. The effects of potassium channel inhibitors on lymphocyte
alcium inﬂux
Earlier studies were limited to the investigation of potassium
hannels in naive and memory lymphocytes. We  have extended
hese ﬁndings to signiﬁcant effector T lymphocyte subsets, and
ound a different pattern of sensitivity to the inhibition of lym-
hocyte potassium channels in Th1 cells of autoimmune patients
RA, MS,  T1DM) compared to healthy individuals (Toldi et al., 2010,
011, 2013). In the investigated autoimmune patients a greater
ecrease of calcium inﬂux upon the inhibition of the Kv1.3 chan-
el than that of the IKCa1 channel was observed in Th1 cells. This
nding is of special interest, since Th1 cells are regarded as key
layers in the mediation of pro-inﬂammatory responses. How-
ver, the selectivity of the investigated inhibitors was  limited in
ur experiments, as they did not only affect a single subset, as
reviously suggested. Although in earlier observations the inhi-
ition of Kv1.3 channels speciﬁcally blocked the function of TEM
ells, our investigations extending to signiﬁcant effector T lym-
hocyte subsets demonstrated that the inhibitory effect is present
ot only in disease-associated CD8 and Th1 cells, but also in the
nti-inﬂammatory Th2 subset.
However, previous data harmonizing with our results suggest
hat selective modulation of lymphocyte activation through spe-
iﬁc inhibition of potassium channels may  be a possible therapeutic
pproach for the treatment of autoimmune disease, peripheral T-
ymphocytes in pSS were insensitive to the potassium channel
nhibitors.
.4. Kv1.3 channel expression in pSS in the investigated
ymphocyte subsets
The insensitivity of peripheral T-lymphocytes in pSS to the
otassium channel inhibitors results may  be due to altered func-
ionality or changes in the expression of Kv1.3 channels. We
herefore analyzed cell surface expression of Kv1.3 channel by
easuring median ﬂuorescence of speciﬁc antibodies. Changes to
he sensitivity of Kv1.3 channel inhibition seem to be related toPlease cite this article in press as: Legány, N., et al., Calcium inﬂux
lymphocytes in primary Sjögren’s syndrome. Immunobiology (2016),
ts altered expression, and therefore, might explain our ﬁndings.
ence, functional alterations of the Kv1.3 channel must also play a
ole in differential sensitivity upon inhibition detected between pSS
atients and healthy controls. Of note, due to the lack of commer- PRESS
gy xxx (2016) xxx–xxx
cially available antibodies against the other investigated potassium
channel, we could not perform a similar measurement in case of
IKCa1.
5. Conclusion
In conclusion, the altered expression of Kv1.3 channels and
speciﬁc inhibition of potassium channels seem to be related to
altered calcium inﬂux kinetics in pSS which distinguish pSS either
from healthy controls or other systemic autoimmune diseases.
These observations support the differential pathomechanism of
pSS. Therefore, further studies, including the analysis of other lym-
phocytes subsets and functional consequences of speciﬁc inhibition
of potassium channels such as cytokine production would add valu-
able information.
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